Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Nipro Mulls M&A to Grow Own-Brand Generic Drugs Lineup

Filed Under: Industry, Pharma Tagged With: , , , , ,

Nipro Corp. (TYO:8086) CEO and President Yoshihiko Sano recently revealed that following the acquisition of Tanabe Seiyaku Hanbai Co. Ltd.,…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
India Moves to Shed Dependence on China for Active Pharmaceutical Ingredients
India Moves to Shed Dependence on China for Active…
Teijin Expands Health Care Operations for Bone and Joint Diseases
Teijin Expands Health Care Operations for Bone and Joint…
Teijin Integrates Automotive Composites Operations Into Singular Global Brand
Teijin Integrates Automotive Composites Operations Into…
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Chemical and Material Companies Look to Take Pharmaceutical Operations to the Next Stage
Chemical and Material Companies Look to Take Pharmaceutical…